{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:01:08Z","timestamp":1793815268898,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271845"],"award-info":[{"award-number":["82271845"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371821"],"award-info":[{"award-number":["82371821"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04172-1","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T03:11:12Z","timestamp":1738638672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intranasal delivery of hMSC-derived supernatant for treatment of ischemic stroke by inhibiting the pro-inflammatory polarization of neutrophils"],"prefix":"10.1186","volume":"16","author":[{"given":"Yixiang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xidan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"issue":"9","key":"4172_CR1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.2022.1420","volume":"327","author":"K Walter","year":"2022","unstructured":"Walter K. What is acute ischemic stroke? JAMA. 2022;327(9):885. https:\/\/doi.org\/10.1001\/jama.2022.1420.","journal-title":"JAMA"},{"key":"4172_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00337-x","author":"PB Sporns","year":"2022","unstructured":"Sporns PB, Fullerton HJ, Lee S, Kim H, Lo WD, Mackay MT, et al. Childhood stroke. Nat Rev Disease Primers. 2022. https:\/\/doi.org\/10.1038\/s41572-022-00337-x.","journal-title":"Nat Rev Disease Primers."},{"key":"4172_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114727","author":"SR Challa","year":"2024","unstructured":"Challa SR, Nalamolu KR, Fornal CA, Baker IM, Mohandass A, Mada SR, et al. The paradox of tPA in ischemic stroke: tPA knockdown following recanalization improves functional and histological outcomes. Exp Neurol. 2024. https:\/\/doi.org\/10.1016\/j.expneurol.2024.114727.","journal-title":"Exp Neurol"},{"key":"4172_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jconrel.2022.02.036","volume":"344","author":"S Zhang","year":"2022","unstructured":"Zhang S, Zhou Y, Li R, Chen Z, Fan X. Advanced drug delivery system against ischemic stroke. J Control Release. 2022;344:173\u2013201.","journal-title":"J Control Release"},{"key":"4172_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02181-4","author":"Y Feng","year":"2021","unstructured":"Feng Y, Li Y, Zhang Y, Zhang B-H, Zhao H, Zhao X, et al. miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling. J Neuroinflammation. 2021. https:\/\/doi.org\/10.1186\/s12974-021-02181-4.","journal-title":"J Neuroinflammation."},{"key":"4172_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00943-7","author":"JH DeLong","year":"2022","unstructured":"DeLong JH, Ohashi SN, O\u2019Connor KC, Sansing LH. Inflammatory responses after ischemic stroke. Seminars Immunopathol. 2022. https:\/\/doi.org\/10.1007\/s00281-022-00943-7.","journal-title":"Seminars Immunopathol."},{"key":"4172_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02447-5","author":"X Li","year":"2022","unstructured":"Li X, Lyu J, Li R, Jain V, Shen Y, del \u00c1guila \u00c1, et al. Single-cell transcriptomic analysis of the immune cell landscape in the aged mouse brain after ischemic stroke. J Neuroinflammation. 2022. https:\/\/doi.org\/10.1186\/s12974-022-02447-5.","journal-title":"J Neuroinflammation"},{"key":"4172_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-022-00383-2","author":"X Zeng","year":"2022","unstructured":"Zeng X, Zhang Y-D, Ma R-Y, Chen Y-J, Xiang X-M, Hou D-Y, et al. Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1\/RIP3-exosome axis. Mil Med Res. 2022. https:\/\/doi.org\/10.1186\/s40779-022-00383-2.","journal-title":"Mil Med Res."},{"key":"4172_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jconrel.2020.04.017","volume":"323","author":"R Upadhya","year":"2020","unstructured":"Upadhya R, Zingg W, Shetty S, Shetty AK. Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders. J Control Release. 2020;323:225\u201339.","journal-title":"J Control Release"},{"key":"4172_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/STROKEAHA.123.043764","volume":"55","author":"PT Ronaldson","year":"2024","unstructured":"Ronaldson PT, Williams EI, Betterton RD, Stanton JA, Nilles KL, Davis TP. CNS drug delivery in Stroke: improving therapeutic translation from the bench to the bedside. Stroke. 2024;55:190\u2013202.","journal-title":"Stroke"},{"key":"4172_CR11","doi-asserted-by":"publisher","first-page":"14503","DOI":"10.1021\/acsnano.2c04886","volume":"16","author":"H Yang","year":"2022","unstructured":"Yang H, Han M, Li J, Ke H, Kong Y, Wang W, et al. Delivery of miRNAs through Metal-Organic framework nanoparticles for assisting neural stem cell therapy for ischemic stroke. ACS Nano. 2022;16:14503\u201316.","journal-title":"ACS Nano"},{"key":"4172_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2023.03.033","volume":"357","author":"X Zhou","year":"2023","unstructured":"Zhou X, Deng X, Liu M, He M, Long W, Xu Z, et al. Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy. J Control Release. 2023;357:1\u201319.","journal-title":"J Control Release"},{"key":"4172_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15963","author":"A Clemente-Morag\u00f3n","year":"2022","unstructured":"Clemente-Morag\u00f3n A, Oliver E, Calle D, Cuss\u00f3 L, Tech MG, Pradillo JM, et al. Neutrophil \u03b21 adrenoceptor blockade blunts stroke-associated neuroinflammation. British J Pharmacol. 2022. https:\/\/doi.org\/10.1111\/bph.15963.","journal-title":"British J Pharmacol"},{"key":"4172_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2017.10.001","author":"X Jiang","year":"2018","unstructured":"Jiang X, Andjelkovic AV, Zhu L, Yang T, Bennett MVL, Chen J, et al. Blood-brain barrier dysfunction and recovery after ischemic stroke. Progress Neurobiology. 2018. https:\/\/doi.org\/10.1016\/j.pneurobio.2017.10.001.","journal-title":"Progress Neurobiology"},{"key":"4172_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2116833","author":"W Cai","year":"2022","unstructured":"Cai W, Hu M, Li C, Wu R, Lu D, Xie C, et al. 2022 FOXP3+ macrophage represses acute ischemic stroke-induced neural inflammation. Autophagy. 2022. https:\/\/doi.org\/10.1080\/15548627.2022.2116833.","journal-title":"Autophagy"},{"key":"4172_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue R, Zhang Q, Cao Q, Kong R, Xiang X, Liu H, et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612:141\u20137.","journal-title":"Nature"},{"key":"4172_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03481-0","author":"X Qi","year":"2021","unstructured":"Qi X, Yu Y, Sun R, Huang J, Liu L, Yang Y, et al. Identification and characterization of neutrophil heterogeneity in sepsis. Critical Care. 2021. https:\/\/doi.org\/10.1186\/s13054-021-03481-0.","journal-title":"Critical Care."},{"key":"4172_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.it.2019.04.012","volume":"40","author":"C Silvestre-Roig","year":"2019","unstructured":"Silvestre-Roig C, Fridlender ZG, Glogauer M, Scapini P. Neutrophil diversity in health and disease. Trends Immunol. 2019;40:565\u201383.","journal-title":"Trends Immunol"},{"key":"4172_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02988-3","author":"RI Sienel","year":"2023","unstructured":"Sienel RI, Mamrak U, Biller J, Roth S, Zellner A, Parakaw T, et al. Inhaled nitric oxide suppresses neuroinflammation in experimental ischemic stroke. J Neuroinflammation. 2023. https:\/\/doi.org\/10.1186\/s12974-023-02988-3.","journal-title":"J Neuroinflammation"},{"key":"4172_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154225","author":"F Denorme","year":"2022","unstructured":"Denorme F, Portier I, Rustad JL, Cody MJ, de Araujo CV, Hoki C, et al. Neutrophil extracellular traps regulate ischemic stroke brain injury. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI154225.","journal-title":"J Clin Invest"},{"key":"4172_CR21","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1111\/cns.14368","volume":"29","author":"M Bai","year":"2023","unstructured":"Bai M, Sun R, Cao B, Feng J, Wang J. Monocyte-related cytokines\/chemokines in cerebral ischemic stroke. CNS Neurosci Therapeutics. 2023;29:3693\u2013712.","journal-title":"CNS Neurosci Therapeutics."},{"key":"4172_CR22","doi-asserted-by":"publisher","first-page":"110991","DOI":"10.1016\/j.intimp.2023.110991","volume":"124","author":"D Li","year":"2023","unstructured":"Li D, He L, Yuan C, Ai Y, Yang J-J. Peroxisome proliferator-activated receptor gamma agonist pioglitazone alleviates hemorrhage-induced thalamic pain and neuroinflammation. Int Immunopharmacol. 2023;124:110991\u20131001.","journal-title":"Int Immunopharmacol"},{"key":"4172_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01064-1","author":"C Qin","year":"2022","unstructured":"Qin C, Yang S, Chu Y-H, Zhang H, Pang X-W, Chen L, et al. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022. https:\/\/doi.org\/10.1038\/s41392-022-01064-1.","journal-title":"Signal Transduct Target Ther."},{"key":"4172_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.122.036946","author":"E Candelario-Jalil","year":"2022","unstructured":"Candelario-Jalil E, Dijkhuizen RM, Magnus T. Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke. 2022. https:\/\/doi.org\/10.1161\/STROKEAHA.122.036946.","journal-title":"Stroke."},{"key":"4172_CR25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00136.2018","author":"C Yang","year":"2019","unstructured":"Yang C, Hawkins KE, Dor\u00e9 S, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol-Cell Physiolgy. 2019. https:\/\/doi.org\/10.1152\/ajpcell.00136.2018.","journal-title":"Am J Physiol-Cell Physiolgy"},{"key":"4172_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678744","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Zhang C, Chen A, Wang H, Zhou Y, Li Y, et al. Immune cells in the BBB disruption after acute ischemic stroke: targets for immune therapy? Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.678744.","journal-title":"Front Immunol."},{"key":"4172_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.it.2019.04.013","volume":"40","author":"A Hidalgo","year":"2019","unstructured":"Hidalgo A, Chilvers ER, Summers C, Koenderman L. The neutrophil life cycle. Trends Immunol. 2019;40:584\u201397.","journal-title":"Trends Immunol"},{"key":"4172_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1095098","author":"C Zhang","year":"2023","unstructured":"Zhang C, Zhang J, Zhang Y, Song Z, Bian J, Yi H, et al. Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1095098.","journal-title":"Front Immunol."},{"issue":"2","key":"4172_CR29","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1530\/ERC-18-0449","volume":"26","author":"PA Furth","year":"2019","unstructured":"Furth PA. Peroxisome proliferator-activated receptor gamma and BRCA1. Endocrine-Related Cancer. 2019;26(2):R73\u20139. https:\/\/doi.org\/10.1530\/ERC-18-0449.","journal-title":"Endocrine-Related Cancer"},{"key":"4172_CR30","doi-asserted-by":"publisher","first-page":"155489","DOI":"10.1016\/j.phymed.2024.155489","volume":"128","author":"J Shi","year":"2024","unstructured":"Shi J, Yang M, Yang S, Fan F, Zheng G, Miao Y, et al. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1\/p53 pathways in LDLR\u2212\/\u2212 mice. Phytomedicine. 2024;128:155489. https:\/\/doi.org\/10.1016\/j.phymed.2024.155489.","journal-title":"Phytomedicine"},{"issue":"2","key":"4172_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.yexcr.2016.03.007","volume":"342","author":"FS Lakschevitz","year":"2016","unstructured":"Lakschevitz FS, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342(2):200\u20139.","journal-title":"Exp Cell Res"},{"issue":"4","key":"4172_CR32","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1182\/blood.V78.4.1105.1105","volume":"78","author":"TW Kuijpers","year":"1991","unstructured":"Kuijpers TW, Tool ATJ, Van der Schoot CE, Ginsel LA, Onderwater JJM, Roos DVAJ, Verhoeven AJ. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood. 1991;78(4):1105\u201311.","journal-title":"Blood"},{"key":"4172_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01862-x","author":"Y Wang","year":"2023","unstructured":"Wang Y, Niu H, Li L, Han J, Liu Z, Chu M, et al. Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia\/reperfusion injury mice inhibiting neuron ferroptosis. J Nanobiotechnol. 2023. https:\/\/doi.org\/10.1186\/s12951-023-01862-x.","journal-title":"J Nanobiotechnol"},{"key":"4172_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.754502","author":"L Manni","year":"2021","unstructured":"Manni L, Conti G, Chiaretti A, Soligo M. Intranasal delivery of nerve growth factor in neurodegenerative diseases and neurotrauma. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.754502.","journal-title":"Front Pharmacol"},{"key":"4172_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103371","volume":"27","author":"D Patel","year":"2022","unstructured":"Patel D, Patel B, Wairkar S. Intranasal delivery of biotechnology-based therapeutics. Drug Discov Today. 2022;27: 103371.","journal-title":"Drug Discov Today"},{"key":"4172_CR36","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/pharmaceutics12111120","volume":"12","author":"EM Rhea","year":"2020","unstructured":"Rhea EM, Logsdon AF, Banks WA, Erickson ME. Intranasal delivery: effects on the neuroimmune axes and treatment of neuroinflammation. Pharmaceutics. 2020;12:1120.","journal-title":"Pharmaceutics"},{"issue":"3","key":"4172_CR37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12640-020-00290-1","volume":"39","author":"S Simorgh","year":"2021","unstructured":"Simorgh S, Alizadeh R, Shabani R, Karimzadeh F, Seidkhani E, Majidpoor J, et al. Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease. Neurotoxicity Res. 2021;39(3):598\u2013608. https:\/\/doi.org\/10.1007\/s12640-020-00290-1.","journal-title":"Neurotoxicity Res"},{"issue":"4","key":"4172_CR38","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/STROKEAHA.122.041507","volume":"54","author":"W Zhang","year":"2023","unstructured":"Zhang W, Hongjian P, Xiaoming H, Shi Y, Leak RK, Anne Stetler R, et al. Poststroke intravenous transplantation of human mesenchymal stem cells improves brain repair dynamics and functional outcomes in aged mice. Stroke. 2023;54(4):1088\u201398. https:\/\/doi.org\/10.1161\/STROKEAHA.122.041507.","journal-title":"Stroke"},{"key":"4172_CR39","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1080\/17425247.2023.2279115","volume":"20","author":"KM Dave","year":"2023","unstructured":"Dave KM, Stolz DB, Manickam DS. Delivery of mitochondria-containing extracellular vesicles to the BBB for ischemic stroke therapy. Expert Opin Drug Deliv. 2023;20:1769\u201388.","journal-title":"Expert Opin Drug Deliv"},{"key":"4172_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/stmcls\/sxac057","volume":"40","author":"S Fujii","year":"2022","unstructured":"Fujii S, Miura Y. Immunomodulatory and regenerative effects of MSC-derived extracellular vesicles to treat acute GVHD. Stem Cells. 2022;40:977\u201390.","journal-title":"Stem Cells"},{"key":"4172_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/17474930231207777","volume":"19","author":"A Zietz","year":"2023","unstructured":"Zietz A, Gorey S, Kelly PJ, Katan M, McCabe JJ. Targeting inflammation to reduce recurrent stroke. Int J Stroke. 2023;19:379\u201387.","journal-title":"Int J Stroke"},{"key":"4172_CR42","doi-asserted-by":"publisher","first-page":"e002548","DOI":"10.1136\/jitc-2021-002548","volume":"9","author":"S Liu","year":"2021","unstructured":"Liu S, Zhang H, Li Y, Zhang Y, Bian Y, Zeng Y, et al. S100A4 enhances protumor macrophage polarization by control of PPAR-\u03b3-dependent induction of fatty acid oxidation. J Immunother Cancer. 2021;9:e002548-e2558.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"4172_CR43","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ajpath.2022.02.002","volume":"192","author":"S Kaba","year":"2022","unstructured":"Kaba S, Kawai Y, Tanigami Y, Ohnishi H, Kita T, Yoshimatsu M, et al. Peroxisome proliferator-activated receptor-\u03b3 agonist attenuates vocal fold fibrosis in rats via regulation of macrophage activation. Am J Pathology. 2022;192(5):771\u201382. https:\/\/doi.org\/10.1016\/j.ajpath.2022.02.002.","journal-title":"Am J Pathology"},{"key":"4172_CR44","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41418-020-00650-6","volume":"28","author":"L-Z Rao","year":"2021","unstructured":"Rao L-Z, Wang Y, Zhang L, Wu G, Zhang L, Wang F-X, et al. IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages. Cell Death Differentiation. 2021;28:1270\u201383.","journal-title":"Cell Death Differentiation"},{"key":"4172_CR45","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/BOR.0000000000000810","volume":"33","author":"S Raychaudhuri","year":"2021","unstructured":"Raychaudhuri S, Cheema KS, Raychaudhuri SK, Raychaudhuri SP. Janus kinase\u2013signal transducers and activators of transcription cell signaling in Spondyloarthritis: rationale and evidence for JAK inhibition. Curr Opin Rheumatol. 2021;33:348\u201355.","journal-title":"Curr Opin Rheumatol"},{"key":"4172_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2016.11.018","volume":"793","author":"P Du","year":"2016","unstructured":"Du P, Ma Q, Zhu Z-D, Li G, Wang Y, Li Q-Q, et al. Mechanism of Corilagin interference with IL-13\/STAT6 signaling pathways in hepatic alternative activation macrophages in schistosomiasis-induced liver fibrosis in mouse model. Eur J Pharmacol. 2016;793:119\u201326.","journal-title":"Eur J Pharmacol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04172-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T03:11:15Z","timestamp":1738638675000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04172-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4172"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04172-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The hMSCs used in the study were provided by the Department of Obstetrics at the Second Affiliated Hospital of Harbin Medical University. And the hMSCs were extracted from medical waste (umbilical cords) and donated to our laboratory for the purpose of scientific research. All experimental protocols and procedures were approved by the Institutional Animal Care and Use Committee of Harbin Medical University on September, 2021 (Project title: Efficacy and mechanism of hMSC-derived supernatant administered intranasally in the treatment of experimental ischemic stroke) and carried out in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The Ethics Committee did not issue approval numbers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}